Prime Minister Modi's visit to Washington DC is seen as a mix of diplomatic success and challenges. Despite tensions over tariffs and other issues, the visit fostered advancements in technology ...
KIO-104 is a novel, non-steroidal anti-inflammatory, small molecule inhibitor of dihydroorotate dehydrogenase (DHODH). A Phase 2 clinical trial of KIO-104 for the treatment of retinal inflammation is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback